mitoxantrone has been researched along with Obesity in 2 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Obesity was associated with younger age, lower PSA and alkaline phosphatase levels, and higher performance status, primary Gleason sum, testosterone and hemoglobin compared to absence of obesity." | 1.35 | The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer. ( Armstrong, AJ; de Wit, R; Eisenberger, M; Halabi, S; Tannock, IF, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reder, AT | 1 |
| Centonze, D | 1 |
| Naylor, ML | 1 |
| Nagpal, A | 1 |
| Rajbhandari, R | 1 |
| Altincatal, A | 1 |
| Kim, M | 1 |
| Berdofe, A | 1 |
| Radhakrishnan, M | 1 |
| Jung, E | 1 |
| Sandrock, AW | 1 |
| Smirnakis, K | 1 |
| Popescu, C | 1 |
| de Moor, C | 1 |
| Armstrong, AJ | 1 |
| Halabi, S | 1 |
| de Wit, R | 1 |
| Tannock, IF | 1 |
| Eisenberger, M | 1 |
2 other studies available for mitoxantrone and Obesity
| Article | Year |
|---|---|
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cl | 2021 |
The relationship of body mass index and serum testosterone with disease outcomes in men with castration-resistant metastatic prostate cancer.
Topics: Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Clinica | 2009 |